Archive for February, 2008
Studying health delivery means figuring out which techniques work for getting the interventions to the people who need them the most. It means studying how to scale effective techniques, and studying how we can speed up policy making processes. Sounds simple doesn’t it? Unfortunately, its rarely done and certainly without the scientific rigor we apply […]
White House launches neglected tropical diseases initiative
1 Comment Published February 22nd, 2008 in PolicyRecently, we discussed President Bush’s legacy in Africa and his efforts to tackle HIV/AIDs and malaria (see my previous post here). In the midst of his Africa tour, Bush added another feather to his cap announcing a new plan to tackle neglected tropical diseases (NTDs). For 2008, NTD aid is set at $15 million targeting […]
Overdiagnosis of malaria hurts the patient (and you and me)
0 Comments Published February 21st, 2008 in Drug resistance, DiagnosisMuch of the world still diagnoses malaria clinically (based on symptoms alone without testing for the presence of the parasite). Recently, a Liverpool team working in Mozambique examined the cost to individual patients resulting from the clinical diagnosis of malaria (Malaria Journal - open access). The findings were striking but certainly not surprising. 23 percent […]
The President’s Malaria Initiative and Bush’s legacy in Africa
1 Comment Published February 20th, 2008 in PolicyPresident Bush is on a five country tour through Africa visiting Benin, Rwanda, Tanzania, Ghana, and Liberia. According to the news, the president has been well-received with large crowds following him in the hopes to glimpse a man they see as a strong supporter. Under the current administration, aid to these countries is […]
Ray Chambers, a successful US businessman and philanthropist, was named the UN special envoy for malaria by Secretary General Ban Ki-Moon. Chambers has been charged with a monumental task - to raise $8-$10 billion dollars for malaria control over the next five years and bring malaria mortality as close to zero as possible.
Such grand, disease-specific […]
Anti-teen malaria in the UK: some truth behind the humor
0 Comments Published February 18th, 2008 in ClimateApparently, loitering gangs of teenagers have been wreaking havoc on UK businesses. In response, some shops have adopted a clever, albeit controversial, solution called the Mosquito which takes advantage of age-related differences in hearing abilities. The device emits an irritating high-frequency sound audible only to teens. If that wasn’t enough, someone decided the Mosquito […]
The NY Times covered some controversy surrounding the expanding influence of the Bill and Melinda Gates Foundation. The complaints highlighted by WHO malaria director, Arata Kochi, were two-fold: the risk posed to independent review and diverse viewpoints amongst researchers, and the unwelcome intrusion of the Gates Foundation in the policy-making process.
I think the real questions […]
Search
About
You are currently browsing the topnaman | Malaria blog weblog archives for February, 2008.
Longer entries are truncated. Click the headline of an entry to read it in its entirety.Latest
- Fighting malaria since the Skeeter beaters
- Mosquito syringes and more funded by the Gates foundations grand challenges
- Monitoring antimalarial drug resistance with molecular tools
- Survival - a new BBC global health series showcases malaria
- Launch of the Global Malaria Action Plan
- 2008 World malaria report released
- Resurrecting the past to create a new malaria vaccine
- Malaria elimination or eradication vs control - what is the big deal?
- The grand challenge of eradication - Gates Foundation is looking for new tools
- Malaria (and other communicable diseases) in Southeast Asia
Archives
Categories
- Advocacy (4)
- Climate (2)
- Communication (2)
- Delivery (2)
- Diagnosis (2)
- Drug resistance (6)
- Policy (9)
- Random (2)
- Research (3)
- Surveillance (5)
- Treatment (3)
- Vector control (2)
Categories
- Advocacy (4)
- Climate (2)
- Communication (2)
- Delivery (2)
- Diagnosis (2)
- Drug resistance (6)
- Policy (9)
- Random (2)
- Research (3)
- Surveillance (5)
- Treatment (3)
- Vector control (2)
